Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BrightSpring Health Services, Inc. ( (BTSG) ) has provided an update.
At its May 21, 2026 annual meeting, BrightSpring Health Services reported that 186.46 million shares, representing about 96.53% of voting power as of the March 30, 2026 record date, were present in person or by proxy. Stockholders elected three Class II directors—Olivia Kirtley, Max Lin and Steve Miller—to terms running until the 2029 annual meeting, underscoring continued support for the company’s current board composition.
Investors also approved the ratification of KPMG LLP as BrightSpring’s independent registered public accounting firm for the fiscal year ending December 31, 2026 and backed the advisory, non-binding vote on executive compensation. The strong approval across these proposals signals broad shareholder alignment with the company’s governance, audit oversight and pay practices, reinforcing stability for management and other stakeholders.
The most recent analyst rating on (BTSG) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on BrightSpring Health Services, Inc. stock, see the BTSG Stock Forecast page.
Spark’s Take on BTSG Stock
According to Spark, TipRanks’ AI Analyst, BTSG is a Outperform.
The score is driven primarily by improving fundamentals (return to profitability, solid free cash flow, and healthier balance sheet signals) and supportive earnings-call guidance for strong 2026 growth and EBITDA expansion. The main offsets are stretched technical conditions (overbought signals) and remaining fundamental risks from thin margins and sizable, disclosed IRA/industry headwinds.
To see Spark’s full report on BTSG stock, click here.
More about BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates in the health services industry, providing care-oriented services to patients and healthcare stakeholders. As a publicly traded company, it is governed by a board of directors elected by stockholders and relies on independent auditors to review its financial reporting for fiscal year compliance and transparency.
Average Trading Volume: 2,978,085
Technical Sentiment Signal: Buy
Current Market Cap: $11.36B
For a thorough assessment of BTSG stock, go to TipRanks’ Stock Analysis page.